Aktis Oncology, Inc. Common stock (AKTS) — Financial Flexibility Index
Aktis Oncology, Inc. Common stock (AKTS) has a Financial Flexibility Index of -0.03x as of December 2024. Free cash flow of $-10.57 Million (operating CF $-12.80 Million minus capex $2.23 Million) represents 0% of total liabilities ($413.98 Million). Also explore net asset momentum of Aktis Oncology, Inc. Common stock to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aktis Oncology, Inc. Common stock Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Aktis Oncology, Inc. Common stock across 21 annual periods. Check asset allocation strategy of Aktis Oncology, Inc. Common stock to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Aktis Oncology, Inc. Common stock (2014–2024)
Year-by-year free cash flow to debt coverage for Aktis Oncology, Inc. Common stock. For the full company profile including market capitalisation, see AKTS company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.04x | $17.62 Million | $14.76 Million | $413.98 Million | ▲ +115.7% |
| 2024 | -0.27x | $-34.35 Million | $-40.35 Million | $126.83 Million | ▼ -74.1% |
| 2023 | -0.16x | $-26.24 Million | $-30.00 Million | $168.66 Million | ▲ +70.8% |
| 2023 | -0.53x | $-33.44 Million | $-44.82 Million | $62.68 Million | ▼ -431.3% |
| 2022 | -0.10x | $-15.82 Million | $-18.12 Million | $157.55 Million | ▲ +66.7% |
| 2022 | -0.30x | $-17.48 Million | $-45.20 Million | $57.91 Million | ▲ +0.0% |
| 2021 | -0.30x | $-17.48 Million | $-45.20 Million | $57.91 Million | ▲ +86.4% |
| 2021 | -2.22x | $-16.87 Million | $-29.36 Million | $7.58 Million | ▼ -486.6% |
| 2020 | -0.38x | $-11.35 Million | $-21.30 Million | $29.94 Million | ▲ +0.0% |
| 2020 | -0.38x | $-11.35 Million | $-21.30 Million | $29.94 Million | ▲ +34.5% |
| 2019 | -0.58x | $-12.74 Million | $-17.67 Million | $21.99 Million | ▲ +0.0% |
| 2019 | -0.58x | $-12.74 Million | $-17.67 Million | $21.99 Million | ▼ -24.7% |
| 2018 | -0.46x | $-7.18 Million | $-14.20 Million | $15.46 Million | ▲ +0.0% |
| 2018 | -0.46x | $-7.18 Million | $-14.20 Million | $15.46 Million | ▲ +62.9% |
| 2017 | -1.25x | $-3.86 Million | $-5.55 Million | $3.08 Million | ▲ +0.0% |
| 2017 | -1.25x | $-3.86 Million | $-5.55 Million | $3.08 Million | ▼ -122.2% |
| 2016 | -0.56x | $-1.05 Million | $-1.10 Million | $1.87 Million | ▲ +0.0% |
| 2015 | -0.56x | $-1.05 Million | $-1.10 Million | $1.87 Million | ▲ +78.7% |
| 2015 | -2.65x | $-868.32K | $-980.04K | $327.66K | ▲ +0.0% |
| 2014 | -2.65x | $-868.32K | $-980.04K | $327.66K | ▲ +97.0% |
| 2014 | -88.17x | $-26.98K | $-26.98K | $306.00 | — |